$Denosumab versus zoledronic acid in elderly patients after hip fracture$

Denosumab versus zoledronic acid in elderly patients after hip fracture

Background Two injectable anti-osteoporosis medications, denosumab and zoledronic acid, have been widely used to treat patients with severe osteoporosis. The purpose of this study was to evaluate the real-world effectiveness and adherence of denosumab compared to zoledronic acid in geriatric patient...

Full description

Bibliographic Details
Main Authors:	Seung-Ju Kim, Ji Woon Kim, Dong-Woo Lee
Format:	Article
Language:	English
Published:	SAGE Publishing 2022-12-01
Series:	Journal of Orthopaedic Surgery
Online Access:	https://doi.org/10.1177/10225536221147082

Similar Items

Cost-Effectiveness of Sequential Denosumab/Zoledronic Acid Compared With Zoledronic Acid Monotherapy for Postmenopausal Osteoporotic Women in China
by: Ruxu You, et al.
Published: (2022-03-01)

Once-yearly zoledronic acid in hip fracture prevention
by: Oddom Demontiero, et al.
Published: (2009-03-01)

Denosumab versus zoledronic acid in cases of surgically unsalvageable giant cell tumor of bone: A randomized clinical trial
by: Jiaji Yue, et al.
Published: (2022-08-01)

Denosumab versus zoledronic acid in cases of surgically unsalvageable giant cell tumor of bone: A randomized clinical trial
by: Shenglong Li, et al.
Published: (2019-04-01)

Comparison of Denosumab and Zoledronic acid as neoadjuvant therapy in patients with giant cell tumor of bone
by: Himanshu Kanwat, et al.
Published: (2021-07-01)

Treatment of osteoporosis with annual iv zoledronic acid: effects on hip fracture
by: Rol, et al.
Published: (2009-01-01)

The skeletal-related events of denosumab versus zoledronic acid in patients with bone metastases: A meta-analysis of randomized controlled trials
by: Zhicai Zhang, et al.
Published: (2017-11-01)

Sequential therapy with denosumab and zoledronate for osteoporosis management a randomized controlled trial
by: Hung-Kuan Yen, et al.
Published: (2023-12-01)

Comparison of the Efficacy of Zoledronate and Denosumab in Patients with Acute Osteoporotic Vertebral Compression Fractures: A Randomized Controlled Trial
by: Seong Son, et al.
Published: (2024-04-01)

Outcome of nonoperative treatment for hip fractures in elderly patients: A systematic review of recent literature
by: Seung-Ju Kim, et al.
Published: (2020-07-01)

Denosumab and Zoledronic Acid Differently Affect Circulating Immune Subsets: A Possible Role in the Onset of MRONJ
by: Ilaria Roato, et al.
Published: (2023-10-01)

Potential protective effect of zoledronic acid when switching from long-term therapy of osteoporosis with denosumab
by: O. V. Yakushevskaya
Published: (2021-01-01)

Can denosumab reduce periprosthetic bone loss after bipolar hip arthroplasty?
by: Kwangkyoun Kim
Published: (2020-10-01)

Modern Approaches to Rehabilitation of Patients with Osteoporotic Hip Fracture: the Role of Pathogenetic Therapy with Zoledronic Acid
by: Larisa A. Marchenkova
Published: (2022-04-01)

Percutaneous kyphoplasty combined with zoledronic acid infusion in the treatment of osteoporotic thoracolumbar fractures in the elderly
by: Shi C, et al.
Published: (2018-05-01)

A Multi-Institutional Randomized Controlled Trial to Investigate Whether Zoledronate Prevents Bone Loss After Discontinuation of Denosumab: The Study Protocol of Denosumab Sequential Therapy (DST) Trial
by: Chia-Che Lee, et al.
Published: (2021-09-01)

Indication and adverse event profiles of denosumab and zoledronic acid: based on U.S. FDA adverse event reporting system (FAERS)
by: Si Su, et al.
Published: (2023-11-01)

Cardiovascular Safety in Postmenopausal Women and Men With Osteoporosis Treated With Denosumab and Zoledronic Acid: A Post‐Authorization Safety Study
by: Leslie Spangler, et al.
Published: (2023-10-01)

Efficacy and safety of denosumab versus zoledronic acid in delaying skeletal-related events in patients with gastrointestinal cancer, pancreas-biliary system cancer, and other rare cancers
by: Hiroo Imai, et al.
Published: (2017-03-01)

Lessons learned from long-term side effects after zoledronic acid infusion following denosumab treatment: a case report and review of the literature
by: Ilona Nurmi-Lüthje, et al.
Published: (2022-12-01)

Role of zoledronic acid in treatment of osteoporosis and prevention of fractures
by: A. V. Krivova, et al.
Published: (2022-01-01)

Single Dose Therapy of Zoledronic Acid for the Treatment of Transient Osteoporosis of Hip
by: Sanjay Agarwala, et al.
Published: (2019-06-01)

Osteonecrosis of the Jaw in Myeloma Patients Receiving Denosumab or Zoledronic Acid. Comment on Pivotal Trial by Raje et al. Published on Lancet Oncology
by: Vittorio Fusco, et al.
Published: (2018-09-01)

Giant cell tumour of bone in os sacrum of a prepubertal girl – Surgical and medical treatment with zoledronate and denosumab
by: Signe Sparre Beck-Nielsen, et al.
Published: (2023-06-01)

Complications after internal screw fixation of nondisplaced femoral neck fractures in elderly patients: A systematic review
by: Seung-Ju Kim, et al.
Published: (2020-05-01)

ZOLEDRONIC ACID ADMINISTRATION ENHANCES FRACTURE HEALING IN THE OSTEOPOROTIC FRACTURES IN OVARIECTOMIZED RABBITS
by: Cansabuncu Gokhan, et al.
Published: (2019-05-01)

Denosumab versus zoledronic acid for preventing symptomatic skeletal events in Asian postmenopausal women with oestrogen-receptor-positive advanced breast cancer: an outcome analyses with a mean follow-up of 3 years
by: Chi Zhang, et al.
Published: (2018-11-01)

Denosumab induction and Zoledronic acid maintenance therapy for recurrent unresectable giant cell tumour of the distal tibia: A case report with sustained tumour control after drug withdrawal
by: Gennady N. Machak, et al.
Published: (2024-04-01)

Risk factors analysis in postmenopausal osteoporosis fragility fracture patients after treated with zoledronic acid
by: Ding Yue, et al.
Published: (2017-09-01)

To withhold or to implement bisphosphonate after cementless hip arthroplasty: a dilemma in elderly hip fracture patients
by: Young-Kyun Lee, et al.
Published: (2019-02-01)

Risk factors associated with outcomes of hip fracture surgery in elderly patients
by: Byung Hoon Kim, et al.
Published: (2015-12-01)

Zoledronic acid effectively inhibited periprosthetic bone loss in patients with osteoporosis after cementless total hip arthroplasty
by: Yue Ding, et al.
Published: (2021-04-01)

Response to Comment—Osteonecrosis of the Jaw in Myeloma Patients Receiving Denosumab or Zoledronic Acid. Comment on Pivotal Trial by Raje et al. Published in Lancet Oncology
by: Noopur Raje, et al.
Published: (2019-05-01)

Effects of Anesthesia Techniques on Outcomes after Hip Fracture Surgery in Elderly Patients: A Prospective, Randomized, Controlled Trial
by: Seokyung Shin, et al.
Published: (2020-05-01)

Regional Nerve Block Decreases the Incidence of Postoperative Delirium in Elderly Hip Fracture
by: Eic Ju Lim, et al.
Published: (2021-08-01)

EFFECT OF ZOLEDRONIC ACID THERAPY ON FRACTURE RISK IN THE TREATMENT OF MEN WITH OSTEOPOROSIS
by: Steven Boonen, et al.
Published: (2012-12-01)

The impact of sequential therapy from short-term teriparatide to denosumab compared with denosumab alone in patients with osteoporotic hip fracture: a 1-year follow-up study
by: Chan Ho Park, et al.
Published: (2020-11-01)

The Efficacy of Alendronate Versus Denosumab on Major Osteoporotic Fracture Risk in Elderly Patients With Diabetes Mellitus: A Danish Retrospective Cohort Study
by: Rikke Viggers, et al.
Published: (2022-01-01)

Comparison of denosumab and zoledronic acid for the treatment of solid tumors and multiple myeloma with bone metastasis: a systematic review and meta-analysis based on randomized controlled trials
by: Lianghai Jiang, et al.
Published: (2021-06-01)

Efficacy of zoledronate, denosumab or teriparatide in postmenopausal women with type 2 diabetes mellitus at high risk of fragility fractures: protocol of an open, blinded endpoint randomized controlled pilot trial
by: Trupti Nagendra Prasad, et al.
Published: (2023-10-01)